Evidence map›Paper›PMID 39467687›Full record

ArticleJournal of the American Society for Mass Spectrometry2024

Processing Next-Generation Mass Spectrometry Imaging Data: Principal Component Analysis at Scale.

Kasper Krijnen, Paul Blenkinsopp, Ron M A Heeren, Ian G M Anthony

Abstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Organ-resolved lipid mapping inFrontiers in chemistry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kasper KrijnenThe Maastricht MultiModal Molecular Imaging Institute (M4i), Division of Imaging Mass Spectrometry, Maastricht University, Maastricht 6229 ER, The Netherlands.
Paul BlenkinsoppIonoptika Ltd., Unit B6, Millbrook Cl, Chandler's Ford, Eastleigh, SO53 4BZ, United Kingdom.
Ron M A HeerenThe Maastricht MultiModal Molecular Imaging Institute (M4i), Division of Imaging Mass Spectrometry, Maastricht University, Maastricht 6229 ER, The Netherlands.ORCID 0000-0002-6533-7179
Ian G M AnthonyThe Maastricht MultiModal Molecular Imaging Institute (M4i), Division of Imaging Mass Spectrometry, Maastricht University, Maastricht 6229 ER, The Netherlands.ORCID 0000-0003-0433-8343

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mass spectrometry imaging (MSI) is constantly improving in spatial resolving power, throughput and mass resolution. Although beneficial, these improvements increase data set size and content. The larger data requires correspondingly fast computer-based analyses. However, these analyses often do not scale well with increased data size. Principal component analysis (PCA) is an important analytical tool commonly used with MSI data; however, most PCA algorithms load and process the entire data set within random access memory (RAM) which is most often insufficient for large data sets. PCA algorithms that use less RAM than the data set exist but are usually much slower or sacrifice precision and are rarely used for MSI data processing. Incremental PCA (IPCA) is an alternative algorithm that avoids large RAM allocations while also preserving speed and analytical precision. Here, we demonstrate and benchmark the use of differing implementations of IPCA, PCA, and commercial software on large and often complex MSI data sets. We show that using an already-published Python-based IPCA algorithm, IPCA can be successfully applied to MSI data sets too large to fit with RAM. Furthermore, our benchmarks demonstrate that, contrary to expectations, IPCA is faster than all other tested PCA implementations on all large data sets that can be directly compared.

Indexed as

algorithmincremental principal component analysismass spectrometry imagingprincipal component analysisPythonrandom access memory

Identifiers

PMID39467687
PMCPMC11622226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.